BMRN
BMRN
US09061G1013
BioMarin Pharmaceutical Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
10.61B EUR
11.07B EUR
10.92B EUR
11.43B EUR
Enterprise Value
13.94B EUR
14.4B EUR
10.13B EUR
10.72B EUR
Valuation Multiples
Trailing P/E
148.09x
151.76x
40.63x
70.02x
Forward P/E
8.26x
--
--
--
Price to Sales
3.11x
3.25x
3.37x
4.62x
Price to Book
1.68x
1.75x
1.76x
1.88x
EV/Revenue
4.09x
4.23x
3.13x
4.33x
EV/EBITDA
21.59x
37.34x
21.01x
34.6x
Price to FCF (P/FCF)
124.56x
15.27x
14.38x
20.43x
EV/FCF
163.64x
19.86x
13.35x
19.17x
FCF Yield
0.8%
6.55%
6.95%
4.89%
ende